cnbc semaglutide Novo Nordisk’s latest obesity drug trial disappoints, sending shares tumbling. CNBC’s Charlotte Reed investigates the setback. | International CNBC-TV18's Video on X
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28























